CN Patent
CN102292071B — 包含2-氧代-1-吡咯烷衍生物的药物组合物
Assigned to UCB SA · Expires 2016-08-24 · 10y expired
What this patent protects
本发明涉及药物化合物的速释制剂。
USPTO Abstract
本发明涉及药物化合物的速释制剂。
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.